±ÇÖиô,Nasal septumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Ö»¯Ðͼ××´ÏÙ°©,differentiated thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹Ìå±ú,Pituitary stalkÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÖ×Áö/²¡Àíѧ,thyroid neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÓҰȱËð,visual field defectÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾µûñ¼Èë·,transsphenoidal approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¯Ì¬ÇúÏß,dynamic curveÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹Ìå×äÖÐ,pituitary apoplexyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÛ±íÏÖ,eye manifestationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÓ½»²æ,optic chiasmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êõºó·ÅÉäÖÎÁÆ,Postoperative radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾µûñ¼ÊÖÊõ,transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇÖÏ®ÐÔ´¹ÌåÏÙÁö,invasive pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÓÓÕ·¢µçλ,visual evoked potentialÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÆ¤ÖÊÖ×Áö,adrenocortical tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÖ×Áö/Õï¶Ï,Thyroid neoplasms/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µòÍöÒÖÖÆµ°°×ÖÊÀà,Inhibitor of apoptosis proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈéÍ·×´¼××´ÏÙ°©,papillary thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÆ¤Öʰ©,adrenocortical carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Merkelϸ°û°©,Merkel cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙËèÖÊÖ¬·¾Áö,Adrenal myelolipomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CT·ÂÕæÄÚ¾µ,CT virtual endoscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÔ´ÐÔ¼×È©,Endogenous formaldehydeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶à·¢ÐÔÄÚ·ÖÃÚÏÙÁö²¡2aÐÍ,Multiple endocrine neoplasia type 2aÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂËÅݰ©,Follicular carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±Áܰͽá×ªÒÆ,cervical lymph node metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐÔÊȸõϸ°ûÁö,Malignant pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍ¸Æ,low calciumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØÖ¢¼¡ÎÞÁ¦(MG),Myasthenia gravis (MG)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙ°©,Thymic carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙż·¢Áö,adrenal incidentalomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È«Éí¹ÇɨÃè,whole body bone scanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙδ·Ö»¯°©,anaplastic thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÍâÊȸõϸ°ûÁö,Extra-adrenal pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËèÑù°©,Medullary carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹Ìå´óÏÙÁö,pituitary macroadenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÂËÅÝ×´°©,follicular thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô°©»ùÒòc-met,proto-oncogene c-metÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Þ´ó´¹ÌåÏÙÁö,giant pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÖÜÆÚµ÷¿Øµ°°×,cell cycle regulatory proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÈ«Çгý,Total thyroidectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÂËÅݰ©,Thyroid follicular carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾µûÏÔ΢ÊÖÊõ,Transsphenoidal microsurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙÀà°©,Thymic carcinoidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ýÑõ»¯ÎïøÌåÔöÖ³Òò×ӻÊÜÌå¦Ã,peroxisome proliferator-activated receptor ¦ÃÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÁÛ°©,thyroid squamous cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÈéÍ·×´Ö×Áö,Thyroid papillary carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±ÁܰͽáÇåɨ,Neck dissectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±ÇµûÍâ¿Æ,transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
S100A6µ°°×,S100A6 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÚºÏÏÔÏñ,Fusion imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÈéÍ·×´ÔöÉú,Papillary thyroid hyperplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Masaoka·ÖÆÚ,Masaoka stageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¢öÇøÁܰͽá,Region ¢ö lymph nodesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºÏ¸°ûÔöÉú,Islet cell hyperplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÖ×Áö/²¡Àíѧ,Adrenal gland neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±²¿Áܰͽá×ªÒÆ,neck lymph node metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒìλÊȸõϸ°ûÁö,Ectopic pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈéÍ·×´ÔöÉú,papillary hyperplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±²¿ÁܰͽáÇåɨÊõ,Neck dissectionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ôÉÏËø¿×ÈË·,Supraorbital keyhole approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙÁܰÍÁö,Thymic lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ´ÎÈ«Çгý,Subtotal thyroidectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙ½Úϸ°ûÉñ¾Áö,adrenal ganglioneuromaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²ÊÉ«¶àÆÕÀÕ³¬ÉùѪÁ÷ÏÔÏñ,Color Doppler flow imageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒþÄäÐÔ¼××´ÏÙ°©,Occult thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔÐØÏÙÁܰÍÁö,Primary thymic lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ¶ñÐÔÖ×Áö,Thyroid neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ¹¦ÄÜÐÔÒȵºÏ¸°ûÁö/Õï¶Ï,Non-functional Islet Cell Tumor/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙÉÏÆ¤Ö×Áö,thymic epithelial tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Þ´ó¼××´ÏÙÖ×Áö,the giant tumor ofthyroidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØ¹Çǰ¾¶Â·,Anterior chest approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ°©Ï¸°û,thyroid cancer cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÎÞ¹¦ÄÜÁö,Nonfunctioning adrenal adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÖ×Áö/Õï¶Ï,adrenal gland neplasms/DIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙÉñ¾ÄÚ·ÖÃÚ°©,thymic neuroendocrine carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ƤÏÂ×ªÒÆ,Subcutaneous metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú³¤¼¤ËØÁö,GH-secreting adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥±Ç¿×¾µû,single-nostril transsphenoidalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÖÊõÑ¡Ôñ,operational choicesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºÏ¸°û/Õï¶Ï,islet cell/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÈËáϸ°û°©,oncocytic carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐÔÒȵºËØÁö,Malignant insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áöϸ°ûºËÈËÊóǶºÏµ¥¿¹,Chimeric monoclonal antibody(chTNT)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßЧҺÏàÉ«Æ×-µç»¯Ñ§·¨,HPLC ECDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏÇ»¾²ÂöÖû»Êõ,Replacement of superior vena cavaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HBME-1µ°°×,HBME 1 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Kϸ°û,NK cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼Ò×åÐÔÊȸõϸ°ûÁö,familial pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ú³¥ÐÔÔöÉú,compensatory renal growthÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ΢°©,thyroid microcancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÕïÁÆÌå»á,therapy practiceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸£¶ûÂíÁ̶ֹ¨×éÖ¯,Tissue fixed in formalinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CT·ÂÕæÄÚ¿ú¾µ,CT virtual endoscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬ÉùͼÏñÌØÕ÷,Ultrasonic feataures invesligationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´©´Ìϸ°ûѧ¼ì²é,Fine needle aspiration cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ïûñ¨ÌÀ,Xiao Ying DecoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Ö»¯Ðͼ××´ÏÙÖ×Áö,differentiated thyroid neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÓ¹¦ÄÜÕϰ,visual function damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±í´ïʧ»î,expression silencingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|